A new experimental drug from Indianapolis-based Eli Lilly and Co. has been found to have a risk of major bleeding, sometimes even death, a report says.
While the company's new blood thinner called prasugrel has been found to reduce the risk of heart attacks, it also has been found to have an inherent risk of major bleeding, The Indianapolis Star reported Sunday.
A three-year study into the new medication found that patients already at a high risk of bleeding could be harmed by taking the experimental drug.
In some of these patients, that typically include individuals with a history of strokes and the elderly, this increased bleeding can prove to be fatal, the report said.
A spokeswoman for the company said researchers would attempt to adjust the drug's dosage levels to prevent such side effects, but still praised the medication's positive attributes.
"This is very promising news to those with acute coronary syndrome," spokeswoman Janice Chavers told the Star of the prasugrel results.
Copyright 2007 by United Press International
Related stories:
Gene is likely cause of stroke-inducing vascular malformations
UCSF scientists have discovered that a gene controlling whether blood vessels differentiate into arteries or veins during embryonic development is linked to a vascular disorder in the brain that causes stroke.
Early onset gene for inflammatory bowel diseases identified
A study of Crohn's disease and ulcerative colitis in children has identified a gene that influences whether children get these diseases early in life, and points to a potential new target for treatment. The findings of the international team that performed the study were published online this week by the journal
Nature Genetics.
Best use of drug-eluting stents
Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction. The use of drug-eluting stents necessitates extended treatment with dual antiplatelet therapy (aspirin plus thienopyridine) which may cause bleeding complications and interferes with or even precludes surgery in case this is needed.
Physicists Rule Out the Production of Dangerous Black Holes at the LHC
(PhysOrg.com) -- On August 8, the world's largest particle accelerator, the Large Hadron Collider near Geneva, Switzerland, began the process of slowly throttling to full power. When its proton beams are circling at full speed and collisions begin, scientists from around the world will finally be able to start collecting data.
New master switch found in the brain that regulates appetite and reproduction
Body weight and fertility have long known to be related to each other – women who are too thin, for example, can have trouble becoming pregnant. Now, a master switch has been found in the brain of mice that controls both, and researchers at the Salk Institute for Biological Studies say it may work the same way in humans.
Soft economy speeds newspaper decline, job cuts
(AP) -- The newspaper industry's downward spiral is accelerating as the weak U.S. economy depresses already-tumbling advertising revenue and forces more rounds of job cuts and other trims.
Jumping for joy... and stronger bones
High impact activities such as jumping and skipping that can easily be incorporated into warm-ups before sports and physical education classes, have been shown to benefit bone health in adolescents.
More aortic chest aneurysms being treated with less-invasive stents
An estimated 60,000 Americans are walking around with time bombs in their chests called thoracic aortic aneurysms. At any time, their main chest artery could suddenly burst open, causing massive internal bleeding that is almost always fatal.